TTM
$8.94B
YoY change
+6.6%
5Y CAGR
+20.9%
Peak year (FY2025)
$18.3B
Cumulative net income
$228B
Net Income history chart for Merck & Co. (MRK) from 2016 to 2025
Latest: $18.3B
Net Income growth chart for Merck & Co. (MRK) from 2016 to 2025
Latest: +6.6%
Net Income history table for Merck & Co. (MRK) from 1985 to 2025
| FY2025 | $18.3B | +6.6% | +$1.14B | ||
| FY2024 | $17.1B | +4589.6% | +$16.8B | ||
| FY2023 | $365M | -97.5% | -$14.2B | ||
| FY2022 | $14.5B | +11.3% | +$1.47B | ||
| FY2021 | $13B | +84.6% | +$5.98B | ||
| FY2020 | $7.07B | -28.2% | -$2.78B | ||
| FY2019 | $9.84B | +58.2% | +$3.62B | ||
| FY2018 | $6.22B | +159.8% | +$3.83B | ||
| FY2017 | $2.39B | -38.9% | -$1.53B | ||
| FY2016 | $3.92B | -11.8% | -$522M | ||
| FY2015 | $4.44B | -62.7% | -$7.48B | ||
| FY2014 | $11.9B | +170.7% | +$7.52B | ||
| FY2013 | $4.4B | -28.6% | -$1.76B | ||
| FY2012 | $6.17B | -1.7% | -$104M | ||
| FY2011 | $6.27B | +628.5% | +$5.41B | ||
| FY2010 | $861M | -93.3% | -$12B | ||
| FY2009 | $12.9B | +65.2% | +$5.09B | ||
| FY2008 | $7.81B | +138.4% | +$4.53B | ||
| FY2007 | $3.28B | -26.1% | -$1.16B | ||
| FY2006 | $4.43B | -4.3% | -$198M | ||
| FY2005 | $4.63B | -20.6% | -$1.2B | ||
| FY2004 | $5.83B | -14.7% | -$1B | ||
| FY2003 | $6.83B | -4.5% | -$319M | ||
| FY2002 | $7.15B | -1.8% | -$132M | ||
| FY2001 | $7.28B | +6.7% | +$460M | ||
| FY2000 | $6.82B | +15.8% | +$931M | ||
| FY1999 | $5.89B | +12.2% | +$642M | ||
| FY1998 | $5.25B | +13.7% | +$634M | ||
| FY1997 | $4.61B | +18.9% | +$733M | ||
| FY1996 | $3.88B | +16.4% | +$546M | ||
| FY1995 | $3.34B | +11.3% | +$338M | ||
| FY1994 | $3B | +38.4% | +$831M | ||
| FY1993 | $2.17B | +9.2% | +$182M | ||
| FY1992 | $1.98B | -6.5% | -$138M | ||
| FY1991 | $2.12B | +19.1% | +$341M | ||
| FY1990 | $1.78B | +19.1% | +$286M | ||
| FY1989 | $1.5B | +23.9% | +$289M | ||
| FY1988 | $1.21B | +33.1% | +$300M | ||
| FY1987 | $906M | +34.1% | +$231M | ||
| FY1986 | $676M | +25.2% | +$136M | ||
| FY1985 | $540M | — | — |
- FY2025$18.3B+6.6%
- FY2024$17.1B+4589.6%
- FY2023$365M-97.5%
- FY2022$14.5B+11.3%
- FY2021$13B+84.6%
- FY2020$7.07B-28.2%
- FY2019$9.84B+58.2%
- FY2018$6.22B+159.8%
- FY2017$2.39B-38.9%
- FY2016$3.92B-11.8%
- FY2015$4.44B-62.7%
- FY2014$11.9B+170.7%
- FY2013$4.4B-28.6%
- FY2012$6.17B-1.7%
- FY2011$6.27B+628.5%
- FY2010$861M-93.3%
- FY2009$12.9B+65.2%
- FY2008$7.81B+138.4%
- FY2007$3.28B-26.1%
- FY2006$4.43B-4.3%
- FY2005$4.63B-20.6%
- FY2004$5.83B-14.7%
- FY2003$6.83B-4.5%
- FY2002$7.15B-1.8%
- FY2001$7.28B+6.7%
- FY2000$6.82B+15.8%
- FY1999$5.89B+12.2%
- FY1998$5.25B+13.7%
- FY1997$4.61B+18.9%
- FY1996$3.88B+16.4%
- FY1995$3.34B+11.3%
- FY1994$3B+38.4%
- FY1993$2.17B+9.2%
- FY1992$1.98B-6.5%
- FY1991$2.12B+19.1%
- FY1990$1.78B+19.1%
- FY1989$1.5B+23.9%
- FY1988$1.21B+33.1%
- FY1987$906M+34.1%
- FY1986$676M+25.2%
- FY1985$540M—
Net Income values are taken from Merck & Co.'s reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's current net income (TTM) is $8.94B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Merck & Co. (MRK) reported net income of $18.3B – grew 6.6% year-over-year.
Merck & Co. net income has grown for 2 consecutive years, with a +20.9% compound annual growth rate over 2020–2025 (5 years).
Across the available history, net income reached its high of $18.3B in 2025 and its low of $365M in 2023.
Merck & Co. Net Income by Year
Merck & Co. Net Income 2025: $18.3B
Merck & Co. net income in 2025 was $18.3B, grew 6.6% from 2024. This figure represents the highest annual value in the available history.
Merck & Co. Net Income 2024: $17.1B
2024's net income for Merck & Co. came in at $17.1B, surged 4589.6% from 2023.
Merck & Co. Net Income 2023: $365M
Merck & Co. posted net income of $365M in 2023, plunged 97.5% below 2022. This figure represents the lowest annual value in the available history.
Merck & Co. Net Income 2022: $14.5B
In 2022, Merck & Co. reported net income of $14.5B, grew 11.3% from 2021.
Merck & Co. Net Income 2021: $13B
Merck & Co. net income in 2021 was $13B.
See more financial history for Merck & Co. (MRK).
Sector peers by Net Income
Healthcare peers of Merck & Co. (MRK), ranked by their latest net income
| $26.8B | |
| $20.6B | |
| $16B | |
| $12.1B | |
| $7.71B | |
| $6.74B | |
| $6.52B | |
| $4.23B |
- $26.8B
- $20.6B
- $12.1B
- $7.71B
- $4.23B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.00% TTM
- Dividend Profile2.58% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History7 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.